# Shire Human Genetic Therapies, Inc., Lexington, MA – FDA Inspections

Source: https://www.keypedia.com/companies/shire-human-genetic-therapies-inc/7051823d-8cc7-4d72-8a82-a0de9bbb9497

> Inspection records and compliance data for Shire Human Genetic Therapies, Inc. in Lexington, Massachusetts. 21 FDA inspections on record, 3 Form 483s, last inspected December 18, 2025.

---

## Details

- Name: Shire Human Genetic Therapies, Inc.
- FEI Number: 3009340644
- Address Line 1: 300 Shire Way
- City: Lexington
- State: Massachusetts
- Zip Code: 02421
- Country Name: United States
- Address: 300 Shire Way, Lexington, Massachusetts 02421, United States
- Country: United States

## Related Documents

- [483 - Shire Human Genetic Therapies, Inc. - 2025-12-18](https://www.keypedia.com/records/483/shire-human-genetic-therapies-inc/b6961644-a238-49ea-bb11-3339d61c8541) — source: FDA, date: December 18, 2025
- [FDA Inspection 1297340 - Shire Human Genetic Therapies, Inc. - 2025-12-18](https://www.keypedia.com/records/fda_inspections/shire-human-genetic-therapies-inc/b66e1add-a72b-454b-ae49-945906abc3d0) — source: FDA, date: December 18, 2025
- FDA Inspection 1297340 - Shire Human Genetic Therapies, Inc. - 2025-12-18 — classification: Voluntary Action Indicated (VAI), source: FDA, date: December 18, 2025
- [483 - Shire Human Genetic Therapies, Inc. - 2022-04-22](https://www.keypedia.com/records/483/shire-human-genetic-therapies-inc/91b0c891-d7c9-41c4-856e-464b842ee491) — source: FDA, date: April 22, 2022
- FDA Inspection 1167818 - Shire Human Genetic Therapies, Inc. - 2022-04-22 — classification: Voluntary Action Indicated (VAI), source: FDA, date: April 22, 2022
- [483 - Shire Human Genetic Therapies, Inc. - 2022-03-23](https://www.keypedia.com/records/483/shire-human-genetic-therapies-inc/b0a0181d-afc7-4c9c-a6b0-5e0abb947400) — source: FDA, date: March 23, 2022
- [FDA Inspection 1116968 - Shire Human Genetic Therapies, Inc. - 2020-01-15](https://www.keypedia.com/records/fda_inspections/shire-human-genetic-therapies-inc/1ae8f893-5541-4ec2-bd26-a3c8369df807) — classification: No Action Indicated (NAI), source: FDA, date: January 15, 2020
- FDA Inspection 1106210 - Shire Human Genetic Therapies, Inc. - 2018-11-09 — source: FDA, date: November 9, 2018
- [FDA Inspection 1061705 - Shire Human Genetic Therapies, Inc. - 2018-07-25](https://www.keypedia.com/records/fda_inspections/shire-human-genetic-therapies-inc/48bf3ed1-b711-4574-91fe-82f89a3e920c) — classification: Voluntary Action Indicated (VAI), source: FDA, date: July 25, 2018
- [FDA Inspection 1004081 - Shire Human Genetic Therapies, Inc. - 2017-01-20](https://www.keypedia.com/records/fda_inspections/shire-human-genetic-therapies-inc/2ca1a688-015e-49e3-aa51-cf11d1e11acc) — classification: Voluntary Action Indicated (VAI), source: FDA, date: January 20, 2017
- FDA Inspection 982412 - Shire Human Genetic Therapies, Inc. - 2016-07-28 — classification: No Action Indicated (NAI), source: FDA, date: July 28, 2016
- FDA Inspection 944256 - Shire Human Genetic Therapies, Inc. - 2015-08-14 — classification: Voluntary Action Indicated (VAI), source: FDA, date: August 14, 2015
- [FDA Inspection 939368 - Shire Human Genetic Therapies, Inc. - 2015-07-15](https://www.keypedia.com/records/fda_inspections/shire-human-genetic-therapies-inc/56029fd9-287f-42c6-9c37-df7773bc659f) — classification: Voluntary Action Indicated (VAI), source: FDA, date: July 15, 2015

## Related Companies

- [Tedor Pharma, Inc.](https://www.keypedia.com/companies/tedor-pharma-inc/a9fa17c4-23c1-4bcf-ad03-bb9635bb063d)
- [Noven Pharmaceuticals Inc](https://www.keypedia.com/companies/noven-pharmaceuticals-inc/78cbceb0-5494-46a4-be87-8acf4450fa52)
- [Murty Pharmaceuticals, Inc](https://www.keypedia.com/companies/murty-pharmaceuticals-inc/8d7f8024-f6fd-463e-b94f-63cd3b745e96)
- [Agnitio Inc](https://www.keypedia.com/companies/agnitio-inc/6bcd09b9-e002-45bf-805c-0e4474b1bdfb)
- [Zydus Lifesciences Limited](https://www.keypedia.com/companies/zydus-lifesciences-limited/0de1df3a-c70c-43b9-9a35-4aac9b0413f4)
- [Cosmo S.p.A.](https://www.keypedia.com/companies/cosmo-spa/986e07cc-bedf-42e7-859e-91b78e08ba75)
- [Tianjin Kingyork Pharmaceuticals Co., Ltd](https://www.keypedia.com/companies/tianjin-kingyork-pharmaceuticals-co-ltd/f9a09d47-f6b9-4654-8d4d-dc81f001b5a7)
- [J. B. Chemicals and Pharmaceuticals Limited](https://www.keypedia.com/companies/j-b-chemicals-and-pharmaceuticals-limited/d77ff966-bfe4-483b-8ca9-723a59fcaba5)
- [MW Encap Ltd.(NextPharma Edinburgh)](https://www.keypedia.com/companies/mw-encap-ltdnextpharma-edinburgh/e8cf1af5-d17a-4c79-ba7d-498a371fbc50)
- [MSD International GmbH (Singapore Branch)](https://www.keypedia.com/companies/msd-international-gmbh-singapore-branch/acbc6490-ca0c-4304-8210-a35e4c4cbd79)

## Related Officers

- [company_representative](https://www.keypedia.com/people/scott-lee/337531e8-7f7a-4131-9114-f4074aef421b)
- [issuing_officer](https://www.keypedia.com/people/charles-y-kuo/36d44416-c980-4b33-b62e-ea0761a46a46)
- [Robert J. Martin](https://www.keypedia.com/people/robert-j-martin/8bd5c75a-ec53-4ae5-9739-a39489686cae)
- [Vice President and Head MA Bio Ops.](https://www.keypedia.com/people/james-m-payne/a00b1219-b005-4eca-8f3b-cf5f84573aee)
- [Senior Consumer Safety Officer - Pharmaceutical Quality](https://www.keypedia.com/people/sean-r-marcsisin/45c910a9-9019-4419-9af8-b1c9f3b1e976)
- [Deputy Director](https://www.keypedia.com/people/lori-m-newman/a0e448e4-11ba-4095-b879-feabb8750b3f)